Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study - Concepedia

Concepedia

Publication | Closed Access

Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study

32

Citations

35

References

2022

Year

Daniel Mrak, Elisabeth Simader, Daniela Sieghart, Péter Mandl, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Maximilian Koblischke, Philipp Hofer,

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1